×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
Improving the Informed Consent Process
Session Chair(s)
Kathleen Findlen
Head of Clinical Operations and Project Management
Piramal Life Sciences, United States
Research Consent in Acute Settings: What Works?
Learning Objective : Provide practical, clear, and concise guidelines that clinical trial personnel can use to decide when they could include subjects who cannot consent in a clinical trial; Describe three solutions to obtaining appropriate informed consent from potential participants who are in an acute health care setting; Discuss methods and strategies to improve comprehension of informed consent in clinical trials.
Speaker(s)
Research Consent in Acute Settings: What Works?
Mitchell Parrish, JD, RAC
H Clinical, United States
President
Can Subjects Who Cannot Sign Informed Consent Be Enrolled in My Trial?
Ricardo Nunez, DrMed
Quintiles Inc., United States
Director, Medical. Central Nervous System.
Strategies to Improve the Informed Consent Process to Enhance Comprehension and Recruitment of Ethnically Diverse Populations
Brenda Jamerson, PharmD
Duke University, United States
Center Fellow, Biobehavioral and Social Aspects of Health Disparities